Apr 02 2026
 Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Posted at Apr 02 2026
h in News by

INDIANAPOLIS and BOSTON and LONDON, March 31, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa.

Check out the full article here.

Print page